Follow-up schedule for initial recurrent hepatocellular carcinoma after ablation based on risk classification by Xuqi Sun, Lingling Li, Ning Lyu, Luwen Mu, Jinfa Lai, Ming Zhao

Get full text

Survival benefits of computed tomography-guided thermal ablation for adrenal metastases from hepatocellular carcinoma by Ning Lyu, Yanan Kong, Tao Pan, Luwen Mu, Xuqi Sun, Shaolong Li, Haijing Deng, Jinfa Lai, Ming Zhao

Get full text

Prediction of effective percutaneous transhepatic biliary drainage in patients with hepatocellular carcinoma: A multi-central retrospective study by Haofan Wang, Yitao Mao, Chunning Zhang, Xiaojun Hu, Bin Chen, Luwen Mu, Shuyi Wang, Yifen Lin, Zhanwang Xiang, Mingsheng Huang

Get full text

TACE Combined with Lenvatinib and Camrelizumab for Unresectable Multiple Nodular and Large Hepatocellular Carcinoma (>5 cm) by Zhanwang Xiang MD, Guohong Li MD, Luwen Mu MD, Haofan Wang MD, Churen Zhou MD, Huzheng Yan MD, Mingsheng Huang PhD

Get full text

Ablation Reboots the Response in Advanced Hepatocellular Carcinoma With Stable or Atypical Response During PD-1 Therapy: A Proof-of-Concept Study by Ning Lyu, Yanan Kong, Xiaoxian Li, Luwen Mu, Haijing Deng, Huiming Chen, Meng He, Jinfa Lai, Jibin Li, Hailin Tang, Youen Lin, Ming Zhao

Get full text